Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16349932 | 0.97 | FFAR4 (0.48) | FFAR4FFAR1ALDH1A1NFKB1FDPS | |
| SCHEMBL30100997 | 0.94 | FFAR4 (0.45) | FFAR4FFAR1ALDH1A1NFKB1FDPS | |
| 3-Heptanol SCHEMBL7527598 | 0.94 | — | — | |
| 3-Heptanol SCHEMBL12399 | 0.94 | — | — | |
| 3-Heptanol SCHEMBL26280 | 0.94 | — | — | |
| SCHEMBL30787451 | 0.92 | FFAR1 (0.54) | FFAR4FFAR1ALDH1A1NFKB1FDPS | |
| SCHEMBL30787216 | 0.92 | FFAR1 (0.54) | FFAR4FFAR1NFKB1FDPSGPR84 | |
| 3-Heptanol SCHEMBL2882446 | 0.92 | FFAR4 (0.43) | FFAR4FFAR1ALDH1A1NFKB1FDPS | |
| SCHEMBL30787236 | 0.92 | FFAR1 (0.54) | FFAR4FFAR1ALDH1A1NFKB1FDPS | |
| SCHEMBL30787180 | 0.92 | FFAR1 (0.54) | FFAR4FFAR1ALDH1A1NFKB1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6899753-B2 | Highly bleed-alleviating ink composition | BENQ CORPORATION (TW) | 2005-05-31 | — | — | US | claimed |
| US-20030037700-A1 | Highly bleed-alleviating ink composition | MIND FUSION, LLC | 2003-02-27 | — | — | US | claimed |
| EP-4298182-B1 | DIELECTRIC THERMAL MANAGEMENT FLUIDS AND METHODS FOR USING THEM | CASTROL LTD (GB) | 2025-06-04 | — | — | EP | disclosed |
| US-20240191119-A1 | Dielectric Thermal Management Fluids and Methods for Using Them | CASTROL LIMITED (GB) | 2024-06-13 | — | — | US | disclosed |
| EP-4298182-A1 | DIELECTRIC THERMAL MANAGEMENT FLUIDS AND METHODS FOR USING THEM | Castrol Limited (GB) | 2024-01-03 | — | — | EP | disclosed |
| CN-117203303-A | Dielectric thermal management fluid and method of use thereof | 卡斯特罗尔有限公司 | 2023-12-08 | — | — | CN | disclosed |
| WO-2022180552-A1 | DIELECTRIC THERMAL MANAGEMENT FLUIDS AND METHODS FOR USING THEM | CASTROL LIMITED (GB) | 2022-09-01 | — | — | WO | disclosed |
| CN-109735925-A | Easy dyeing and the polyester of degradation FDY and preparation method thereof | 江苏恒力化纤股份有限公司 | 2019-05-10 | — | — | CN | disclosed |
| EP-2700636-B1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | ASAHI CHEMICAL IND (JP) | 2017-08-02 | — | — | EP | disclosed |
| US-9359324-B2 | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| CN-103476764-B | Process for producing episulfide compound | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2016-05-25 | — | — | CN | disclosed |
| US-8888261-B2 | Image forming method, pretreatment liquid set, and cartridge | RICOH COMPANY, LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2014-04-17 | — | — | US | disclosed |
| EP-2700636-A1 | PROCESS FOR PREPARING EPISULFIDE COMPOUNDS | Asahi Kasei Chemicals Corporation (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-20110279517-A1 | IMAGE FORMING METHOD, PRETREATMENT LIQUID SET, AND CARTRIDGE | RICOH COMPANY, LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| CN-101519552-B | Method for preparing inkjet water-soluble ink containing noble metal nano particles | CHINESE ACAD INST CHEMISTRY | 2011-08-24 | — | — | CN | disclosed |
| CN-101519552-A | Method for preparing inkjet water-soluble ink containing noble metal nano particles | CHINESE ACAD INST CHEMISTRY | 2009-09-02 | — | — | CN | disclosed |
| US-6899753-B2 | Highly bleed-alleviating ink composition | BENQ CORPORATION (TW) | 2005-05-31 | — | — | US | disclosed |
| CN-1401710-A | Ink composition with high ink bleeding prevention | BENQ CORP (CN) | 2003-03-12 | — | — | CN | disclosed |
| US-20030037700-A1 | Highly bleed-alleviating ink composition | MIND FUSION, LLC | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107350-A1 | Process for Preparing Episulfide Compounds | TST, EPHX2, STS | FFAR4 4324/4885FFAR1 4701/4885ALDH1A1 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.